ArticleBritish journal of pharmacology2013

The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential.

A Boehlen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.